¼¼°èÀÇ ¿Âµµ Á¶Àý ÀåÄ¡ ½ÃÀå
Temperature Modulation Devices
»óǰÄÚµå : 1784790
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 190 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,215,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,647,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¿Âµµ Á¶Àý ÀåÄ¡ ½ÃÀåÀº 2030³â±îÁö 41¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 30¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¿Âµµ Á¶Àý ÀåÄ¡ ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 5.3%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 41¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÈÞ´ë¿ë Ç÷¾×/¼ö¾× ¿ö¸Ó´Â CAGR 4.3%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á±îÁö 18¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Àüµµ¼º ȯÀÚ º¸¿Â ½Ã½ºÅÛ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 5.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 8¾ï 1,550¸¸ ´Þ·¯, Áß±¹Àº CAGR8.2%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¿Âµµ Á¶Àý ÀåÄ¡ ½ÃÀåÀº 2024³â¿¡´Â 8¾ï 1,550¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â°£ CAGR 8.2%·Î 2030³â±îÁö 8¾ï 480¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 2.6%¿Í 5.2%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.4%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ¿Âµµ Á¶Àý ÀåÄ¡ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Á¤¹Ð ¿Âµµ Á¦¾î°¡ Çö´ë Ä¡·á¹ýÀÇ ÇÙ½ÉÀÌ µÇ°í ÀÖ´Ù?

¿Âµµ Á¶Àý ÀåÄ¡´Â ´Ù¾çÇÑ ÀÓ»ó »óȲ¿¡¼­ ȯÀÚÀÇ Ã¼¿ÂÀ» Á¤È®ÇÏ°Ô Á¶ÀýÇÒ ¼ö ÀÖ´Â ´É·ÂÀ¸·Î ÀÎÇØ ¼ö¼ú ¹× ºñ¼ö¼ú ÀÇ·á ÇöÀå¿¡¼­ Áß¿äÇÑ Á¸Àç°¨À» µå·¯³»°í ÀÖ½À´Ï´Ù. ÀÌ ±â±âµéÀº Ä¡·á ¸ñÀû¿¡ µû¶ó Àúü¿ÂÀ» À¯µµÇϰųª °íü¿ÂÀ» ¿¹¹æÇϰųª Á¤»ó ü¿ÂÀ» À¯ÁöÇϵµ·Ï ¼³°èµÇ¾î ½ÉÁ¤Áö ȸº¹, ³úÁ¹Áß °ü¸®, ¿Ü»ó¼º ³ú¼Õ»ó(TBI), ¼ö¼ú ÀüÈÄ ÀÇ·á µîÀÇ ºÐ¾ß¿¡¼­ ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ´Â µ¥ ÇʼöÀûÀÎ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. Ä¡·áÀû ü¿Â Á¶ÀýÀ» ÁöÁöÇÏ´Â ÀÓ»óÀû ±Ù°Å°¡ °è¼Ó °­È­µÇ¸é¼­ º´¿ø°ú ÁßȯÀڽǿ¡¼­´Â ħ½ÀÀû, ºñħ½ÀÀû ü¿Â Á¶ÀýÀÌ °¡´ÉÇÑ Ã·´Ü ½Ã½ºÅÛÀ» µµÀÔÇÏ´Â »ç·Ê°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÃֽŠÀåºñ´Â Ç¥¸é ³Ã°¢ ÆÐµå, Ç÷°ü ³» Ä«Å×ÅÍ ¶Ç´Â ÇÏÀ̺긮µå ½Ã½ºÅÛÀ» »ç¿ëÇÏ¿© Ç¥Àû ü¿Â Á¶ÀýÀ» ¼öÇàÇϸç, Á¾Á¾ ÀÚµ¿È­µÈ Çǵå¹é ·çÇÁ¿Í ÅëÇյǾî Á¤È®µµ¸¦ ³ôÀÔ´Ï´Ù. ¼ö¼ú, ƯÈ÷ Àå½Ã°£ ¸¶Ãë ¹× ½ÉÇ÷°ü À§ÇèÀ» ¼ö¹ÝÇÏ´Â ¼ö¼ú Áõ°¡´Â ¼ö¼ú ÈÄ ÇÕº´ÁõÀ» ÁÙÀ̱â À§ÇØ Á¤»ó ü¿Â À¯Áö ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¹Ì±¹½ÉÀåÇùȸ(American Heart Association)¿Í À¯·´¼Ò»ýÇùȸ(European Resuscitation Council)¿Í °°Àº ´ÜüÀÇ °¡À̵å¶óÀÎÀº ½ÉÁ¤Áö ÈÄ ÇÁ·ÎÅäÄÝ¿¡¼­ ü¿Â Á¶ÀýÀÇ Á߿伺À» °­Á¶Çϰí, ½ÃÀå Ãâ½Ã¿¡ ´ëÇÑ ±ÔÁ¦Àû Áö¿øÀ» Á¦°øÇÕ´Ï´Ù. Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Å»ý¾Æ ÁßȯÀÚ½Ç(NICU)°ú ÀÀ±Þ½Ç¿¡¼­´Â ½Å°æ º¸È£¿Í »ýÁ¸À²À» Çâ»ó½Ã۱â À§ÇØ ÀÌ·¯ÇÑ ±â¼úÀ» äÅÃÇϰí ÀÖ¾î ÀÓ»ó Àû¿ëÀÇ ÆøÀÌ ³Ð¾îÁö°í ÀÖÀ½À» ÀÔÁõÇϰí ÀÖ½À´Ï´Ù.

ÁßȯÀÚ Ä¡·á ÇöÀå¿¡¼­ ü¿Â Á¶Àý ±â¼ú¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

¿Âµµ Á¶Àý ÀåÄ¡´Â ÁßȯÀÚ½Ç(ICU)°ú ÀÀ±Þ½Ç¿¡¼­ ÇÁ·ÎÅäÄÝÀÇ Áß½ÉÀÌ µÇ°í ÀÖ½À´Ï´Ù. ³úÁ¹ÁßÀ̳ª Àú»ê¼Ò¼º ÇãÇ÷¼º ³úº´Áõ°ú °°Àº ½Å°æ ¼Õ»ó ȯÀÚ¿¡¼­ ³Ã°¢ ¿ä¹ýÀº ¿°Áõ, ³úºÎÁ¾, ÀÌÂ÷Àû ³ú ¼Õ»óÀ» ÃøÁ¤ÇÒ ¼ö ÀÖÀ» Á¤µµ·Î °¨¼Ò½ÃŰ´Â °ÍÀ¸·Î ÀÔÁõµÇ¾ú½À´Ï´Ù. ¸¶Âù°¡Áö·Î ÆÐÇ÷Áõ ȯÀÚÀÇ ¹ß¿­ °ü¸®´Â ÀÌȯÀ²°ú »ç¸Á·üÀ» °áÁ¤Áþ´Â ¼öÁ¤ °¡´ÉÇÑ ¿äÀÎÀ¸·Î ÀνĵǾî Ç¥¸é ³Ã°¢±â³ª Ç÷°ü ³» ³Ã°¢±âÀÇ º¸±ÞÀ¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù. È­»ó Ä¡·á½Ç¿¡¼­´Â Àå½Ã°£ÀÇ Å»Ç÷À̳ª ÀÌ½Ä ¼ö¼ú Áß ¾ÈÁ¤µÈ ü¿ÂÀ» À¯ÁöÇϱâ À§ÇØ ÀÌ·¯ÇÑ ±â¼úÀ» »ç¿ëÇϰí ÀÖÀ¸¸ç, Àå±â ÀÌ½Ä ÇÁ·Î±×·¥¿¡¼­´Â ¼ö¼ú Àü/ÈÄ Á¶Á÷ »ýÁ¸À²À» ÃÖÀûÈ­Çϱâ À§ÇØ Ã¼¿Â °ü¸®¿¡ ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. ü¿Â Á¶Àý Àå¾Ö¿¡ ƯÈ÷ Ãë¾àÇÑ ¼Ò¾Æ ¹× ³ëÀÎ Áý´Üµµ ¸ÂÃãÇü ¿Âµµ °ü¸® ¼Ö·ç¼ÇÀÇ ÇýÅÃÀ» ´©¸± ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü°¡ °³º°È­µÈ Áõ°Å ±â¹Ý Ä¡·á¸¦ Áß½ÃÇÔ¿¡ µû¶ó ü¿ÂÀ» ¾ö°ÝÇÏ°Ô °ü¸®ÇÏ´Â ´É·ÂÀº ´Ü¼øÇÑ º¸Á¶ ¼ö´ÜÀÌ ¾Æ´Ñ Ä¡·á»óÀÇ ÀÌÁ¡ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¸¶Ãë°ú Àü¹®ÀÇ, ÁßȯÀÚ½Ç Àü¹®ÀÇ, ½Å°æ°ú Àü¹®ÀÇ µî ´ÙÇÐÁ¦ Áø·áÆÀÀÌ Ã¼¿Â Á¶Àý ÇÁ·ÎÅäÄÝÀ» ÀÏ»óÀûÀÎ ¿öÅ©Ç÷ο쿡 ÅëÇÕÇÏ´Â »ç·Ê°¡ ´Ã°í ÀÖÀ¸¸ç, ÀÌ´Â ÀÇ·á ±â°ü¿¡¼­ ü¿Â Á¶Àý ÇÁ·ÎÅäÄÝÀ» ´õ Æø³Ð°Ô ¼ö¿ëÇϰí ÅõÀÚ¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÅÍÄ¡½ºÅ©¸° ÀÎÅÍÆäÀ̽º¿Í ÀÚµ¿ °æ°í ½Ã½ºÅÛ µî ±â±âÀÇ »ç¿ë ÆíÀǼºÀÌ Çâ»óµÇ¾î ÀÇ·áÁøÀÇ ºÎ´ãÀ» ÁÙÀ̰í ü¿Â ¸ñÇ¥ ÁؼöÀ²À» Çâ»ó½ÃÄ×½À´Ï´Ù.

»õ·Î¿î ±â¼úÀÌ Ä¡·á¿ë ³Ã°¢ ¹× °¡¿­ÀÇ ÇѰ踦 ¶Ù¾î³ÑÀ» ¼ö ÀÖÀ»±î?

±â¼úÀº ü¿Â Á¶ÀýÀÇ Àü¸ÁÀ» À籸¼ºÇÏ°í ´õ ¸¹Àº ÀÓ»ó ¿µ¿ª¿¡¼­ Àû¿ë °¡´É¼º°ú È¿´ÉÀ» È®´ëÇÏ´Â µ¥ ÀÖ¾î Çõ½ÅÀûÀÎ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. Â÷¼¼´ë ¿Âµµ Á¶Àý ÀåÄ¡¿¡´Â ȯÀÚÀÇ ¹ÙÀÌÅ»°ú ¹ÝÀÀ ÆÐÅÏ¿¡ µû¶ó ÃÖÀûÀÇ Ã¼¿Â ¹üÀ§¸¦ ¿¹ÃøÇϰí À¯ÁöÇÏ´Â AI ±â¹Ý ¾Ë°í¸®ÁòÀÌ Å¾ÀçµÇ¾î ÀÖ½À´Ï´Ù. ÇÑ½Ã¶óµµ »¡¸® °³ÀÔÀÌ Áß¿äÇÑ ±¸±ÞÂ÷³ª ±º ÇöÀå Ȱµ¿ µî º´¿ø Àü ȯ°æ¿¡¼­ÀÇ Ã¼¿Â °ü¸®¸¦ Áö¿øÇϱâ À§ÇØ ¹«¼±À¸·Î ÈÞ´ë °¡´ÉÇÑ ½Ã½ºÅÛÀÌ µµÀԵǰí ÀÖ½À´Ï´Ù. »ýüÀûÇÕ¼ºÀ» ³ôÀ̰í Á¤¹ÐÇÑ À¯·® Á¶ÀýÀÌ °¡´ÉÇÑ Ç÷°ü ³» ³Ã°¢ Ä«Å×ÅÍ´Â ±Þ¼º±â ÀÇ·á ÇöÀå¿¡¼­ ÇÕº´ÁõÀ» ÁÙÀ̰í, º¸´Ù ºü¸¥ ü¿Â ´Þ¼º ¹× À¯Áö¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÃÖ±Ù¿¡´Â Ŭ¶ó¿ìµå ±â¹Ý µ¥ÀÌÅÍ ·Î±ë ±â´ÉÀ» °®Ãá Á¦Ç°µµ ÀÖ¾î Àü¹®ÀÇÀÇ ½Ç½Ã°£ ¿ø°Ý ¸ð´ÏÅ͸µÀÌ °¡´ÉÇÏ¿© º¹ÀâÇÑ »ç·Ê¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀÌ ¿ëÀÌÇØÁ³½À´Ï´Ù. Ç¥¸é ±â¹Ý ½Ã½ºÅÛµµ ÁøÈ­ÇÏ¿© °í±Þ ÇÏÀ̵å·Î°Ö ÆÐµå, »ó º¯È­ Àç·á, º¸´Ù ±ÕÀÏÇϰí È¿À²ÀûÀÎ ¿­±³È¯À» À§ÇÑ Æó¼â ·çÇÁ À¯Ã¼ ¼øÈ¯À» Ư¡À¸·Î ÇÕ´Ï´Ù. ¶ÇÇÑ, º´¿ø ÀüÀÚ ÀÇ·á ±â·Ï(EHR)°úÀÇ ÅëÇÕÀ» ÅëÇØ ÇÕ¸®ÀûÀÎ ¹®¼­È­ ¹× ¼º°ú ÃßÀûÀÌ °¡´ÉÇØÁ® Ã¥ÀÓ°ú °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¼ö¼ú¿ëÀÇ °æ¿ì, ¸ðµâ½Ä ¿Âµµ Á¦¾î ½Ã½ºÅÛÀ» ¼ö¼ú´ë³ª ¸¶Ãë īƮ¿¡ Á÷Á¢ ÅëÇÕÇÏ¿© ¼ö¼ú ³»³» ¿øÈ°ÇÑ ¿Âµµ Áö¿øÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ¿Âµµ Á¶Àý ÀåÄ¡°¡ ½ÇÇöÇÒ ¼ö ÀÖ´Â ÀÓ»óÀû ÇѰ踦 ³ÐÈ÷°í, ÀÌ¿ë »ç·Ê¸¦ Á¾¾çÇÐ(¿Â¿­ ¿ä¹ý), ½ºÆ÷Ã÷ ÀÇÇÐ(±¹¼Ò ³Ã°¢), ½ÉÁö¾î ¼ÒºñÀÚ °Ç°­±îÁö È®ÀåÇϰí ÀÖ½À´Ï´Ù.

¿Âµµ Á¶Àý ÀåÄ¡ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ±¸Ã¼ÀûÀÎ µ¿ÇâÀº ¹«¾ùÀΰ¡?

¿Âµµ Á¶Àý ÀåÄ¡ ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú ¹ßÀü, ÀÓ»ó ¼ö¿ä, ÀÇ·á °üÇàÀÇ ÁøÈ­¿¡ µû¸¥ ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ƯÈ÷ ³úÁ¹Áß, ½ÉÁ¤Áö, TBI µî Ç¥ÁØ Ä¡·áÀÇ ÀÏȯÀ¸·Î ±Þ¼º ü¿Â °ü¸®°¡ ÇÊ¿äÇÑ ½Å°æ°è ¹× ½ÉÇ÷°ü°è ÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¤Çü¿Ü°ú, ½ÉÀ庴ÇÐ, Á¾¾çÇÐÀ» Áß½ÉÀ¸·Î Àü ¼¼°è ¼ö¼ú °Ç¼ö Áõ°¡µµ Àúü¿ÂÀ¸·Î ÀÎÇÑ ÀÀ°íÀå¾Ö, °¨¿° µîÀÇ ÇÕº´ÁõÀ» ¿¹¹æÇϱâ À§ÇÑ ¼ö¼ú ÀüÈÄ ¿Âµµ °ü¸®¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¼ö¿ä¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. º´¿øµéÀº ÁßȯÀڽǰú ¸¶Ãë ÈÄ Ä¡·á½ÇÀÇ °á°ú¸¦ °³¼±Çϱâ À§ÇÑ ±¤¹üÀ§ÇÑ ³ë·ÂÀÇ ÀÏȯÀ¸·Î ÀÌ·¯ÇÑ Àåºñ¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ±â¼ú Çõ½Åµµ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ÄÄÆÑÆ®ÇÏ°í ¿¡³ÊÁö È¿À²ÀûÀÌ¸ç »ç¿ëÀÚ Ä£È­ÀûÀÎ ½Ã½ºÅÛÀº °í±Þ 3Â÷ º´¿ø°ú Áß±Þ º´¿ø ¸ðµÎ¿¡ ¾îÇÊÇϰí ÀÖ½À´Ï´Ù. ½Å°æ º¸È£ Àü·«¿¡ ´ëÇÑ Àνİú ±³À°ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â ÀÏ»óÀûÀÎ ÁßȯÀÚ Ä¡·á ÇÁ·ÎÅäÄÝ¿¡ ¿Âµµ Á¶ÀýÀ» ÅëÇÕÇϰí ÀÖ½À´Ï´Ù. ºÏ¹Ì¿Í ¼­À¯·´ µîÀÇ Áö¿ª¿¡¼­´Â ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀΰú À¯¸®ÇÑ »óȯ Á¤Ã¥ÀÌ °áÇÕµÇ¾î ½Ã¼³¿¡¼­ÀÇ Ã¤ÅÃÀÌ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿Ü·¡ ¼ö¼ú¼¾ÅÍ, ÀÀ±Þ½Ç, ÀçȰº´¿ø µî ±âÁ¸°ú´Â ´Ù¸¥ ȯ°æÀ¸·Î ¿Âµµ Á¶ÀýÀÌ È®´ëµÇ¸é¼­ °í°´ÃþÀÌ ³Ð¾îÁö°í ÀÖ½À´Ï´Ù. Àåºñ Á¦Á¶¾÷ü¿Í ÀÇ·á½Ã½ºÅÛÀÇ Àü·«Àû Á¦ÈÞ¸¦ ÅëÇÑ Àϰý ¼Ö·ç¼Ç°ú ±º ¹× Àç³­ ´ëÀÀ ±â°ü ¼ö¿ä Áõ°¡·Î »õ·Î¿î ¼öÀÍ Ã¤³ÎÀÌ »ý°Ü³ª°í ÀÖ½À´Ï´Ù. ÇコÄɾ ÇÁ·ÎÅäÄÝ¿¡ ±â¹ÝÇÑ »çÀü ¿¹¹æÀû Ä¡·á ¸ðµ¨·Î °è¼Ó À̵¿ÇÔ¿¡ µû¶ó, ¿Âµµ Á¶Àý ÀåÄ¡ÀÇ Á¤È®¼º°ú ÀûÀÀ¼ºÀº Çö´ë ÀÓ»ó¿¡ ÇʼöÀûÀÎ µµ±¸°¡ µÇ°í ÀÖ½À´Ï´Ù.

ºÎ¹®

À¯Çü(ÈÞ´ë¿ë Ç÷¾×/¼ö¾× º¸¿Â±â, Àüµµ¼º ȯÀÚ º¸¿Â ½Ã½ºÅÛ, ´ë·ù¼º ȯÀÚ º¸¿Â ½Ã½ºÅÛ, Àüµµ¼º ȯÀÚ ³Ã°¢ ½Ã½ºÅÛ, ±âŸ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Temperature Modulation Devices Market to Reach US$4.1 Billion by 2030

The global market for Temperature Modulation Devices estimated at US$3.0 Billion in the year 2024, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Portable Blood / IV fluid warmers, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Conductive patient warming systems segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$815.5 Million While China is Forecast to Grow at 8.2% CAGR

The Temperature Modulation Devices market in the U.S. is estimated at US$815.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$804.8 Million by the year 2030 trailing a CAGR of 8.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Temperature Modulation Devices Market - Key Trends & Drivers Summarized

Is Precision Temperature Control Becoming a Cornerstone of Modern Therapeutics?

Temperature modulation devices are gaining critical prominence in both surgical and non-surgical healthcare settings, driven by their ability to precisely regulate patient body temperature in a range of clinical scenarios. These devices are designed to induce hypothermia, prevent hyperthermia, or maintain normothermia, depending on the therapeutic goal, and they play an essential role in improving patient outcomes in areas such as cardiac arrest recovery, stroke management, traumatic brain injury (TBI), and perioperative care. As the clinical evidence supporting therapeutic temperature modulation continues to strengthen, hospitals and critical care units are increasingly adopting advanced systems capable of invasive and non-invasive temperature management. Modern devices utilize surface cooling pads, intravascular catheters, or hybrid systems to deliver targeted temperature control, often integrated with automated feedback loops for enhanced precision. The rise in surgical procedures-particularly those involving long anesthesia durations or cardiovascular risk-has further fueled demand for normothermia-maintaining systems to reduce post-operative complications. Guidelines from bodies like the American Heart Association and the European Resuscitation Council have reinforced the importance of temperature modulation in post-cardiac arrest protocols, giving a regulatory boost to market adoption. Additionally, neonatal intensive care units (NICUs) and emergency departments are adopting these technologies to improve neuroprotection and survival rates, underscoring the expanding breadth of clinical application.

Why Are Critical Care Settings Increasing Reliance on Thermal Regulation Technologies?

Temperature modulation devices are becoming increasingly central to protocols in intensive care units (ICUs) and emergency departments, as precise thermal control is now considered a vital parameter in critical care. In patients suffering from neurological injuries-such as stroke or hypoxic-ischemic encephalopathy-cooling therapies have demonstrated a measurable reduction in inflammation, cerebral edema, and secondary brain injury. Similarly, febrile management in septic patients is now recognized as a modifiable determinant of morbidity and mortality, leading to the widespread deployment of surface and endovascular cooling devices. Burn care units use these technologies to maintain stable core temperatures during prolonged debridement and grafting procedures, while organ transplant programs rely on temperature control to optimize tissue viability pre- and post-surgery. Pediatric and geriatric populations, particularly vulnerable to temperature dysregulation, are also benefitting from tailored thermal management solutions. As healthcare providers place greater emphasis on personalized, evidence-based care, the ability to tightly control body temperature has become a therapeutic advantage rather than just a supportive measure. Interdisciplinary care teams-including anesthesiologists, intensivists, and neurologists-are increasingly integrating temperature modulation protocols into routine workflows, driving broader acceptance and institutional investment. Moreover, advancements in device usability, such as touch-screen interfaces and automated alert systems, are reducing the burden on healthcare staff and improving compliance with temperature targets.

Can Emerging Technologies Push the Boundaries of Therapeutic Cooling and Warming?

Technology is playing a transformative role in reshaping the landscape of temperature modulation, expanding its applicability and effectiveness across more clinical domains. Next-generation temperature modulation devices are now equipped with AI-powered algorithms that predict and maintain optimal body temperature ranges based on patient vitals and response patterns. Wireless and portable systems are being introduced to support temperature management in pre-hospital settings such as ambulances and military field operations, where time-sensitive interventions are critical. Intravascular cooling catheters with enhanced biocompatibility and precision flow control are reducing complications and enabling faster temperature achievement and maintenance in acute care scenarios. Some devices now come with cloud-based data logging capabilities that allow real-time remote monitoring by specialists, facilitating continuous oversight in complex cases. Surface-based systems are also evolving, featuring advanced hydrogel pads, phase-change materials, and closed-loop fluid circulation for more uniform and efficient heat exchange. Additionally, integration with hospital electronic health records (EHRs) enables streamlined documentation and performance tracking, improving accountability and outcomes. In surgical applications, modular temperature control systems are being embedded directly into operating tables and anesthesia carts to allow seamless thermal support throughout procedures. These innovations are pushing the clinical boundaries of what temperature modulation devices can achieve, expanding their use cases into oncology (for hyperthermia therapy), sports medicine (for localized cooling), and even consumer wellness.

What Specific Trends Are Fueling the Growth of the Temperature Modulation Devices Market?

The growth in the temperature modulation devices market is driven by several factors that align with technological advancement, clinical demand, and evolving healthcare practices. A key driver is the increasing prevalence of neurological and cardiovascular conditions that require acute temperature management as part of standard care-particularly stroke, cardiac arrest, and TBI. The rise in surgical volume worldwide, especially in orthopedics, cardiology, and oncology, is also creating a sustained demand for perioperative temperature control to prevent complications like hypothermia-induced coagulopathy or infection. Hospitals are investing in these devices as part of broader initiatives to improve outcomes in intensive and post-anesthesia care units. Technological innovation is playing a crucial role as well, with compact, energy-efficient, and user-friendly systems that appeal to both high-end tertiary hospitals and mid-size facilities. Increasing awareness and training around neuroprotective strategies are prompting healthcare providers to integrate temperature modulation into routine critical care protocols. Regulatory endorsements, combined with favorable reimbursement policies in regions such as North America and Western Europe, are further propelling institutional adoption. Additionally, the expansion of temperature modulation into non-traditional environments-like ambulatory surgery centers, EMS units, and rehabilitation clinics-is widening the customer base. Strategic collaborations between device manufacturers and health systems for bundled solutions, along with growing demand from military and disaster response agencies, are introducing new revenue channels. As healthcare continues to shift toward proactive, protocol-based care models, the precision and adaptability of temperature modulation devices are making them indispensable tools in the modern clinical arsenal.

SCOPE OF STUDY:

The report analyzes the Temperature Modulation Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Portable Blood / IV fluid warmers, Conductive patient warming systems, Convective patient warming systems, Conductive patient cooling systems, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â